Oral medicine for treating hyperlipemia

A hyperlipidemia and drug technology, applied in the field of plant materials, can solve the problems of heavy economic burden for patients, narrow treatment range, and insignificant curative effect

Inactive Publication Date: 2005-10-12
FOURTH MILITARY MEDICAL UNIVERSITY
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the content of its medicinal ingredients is low, its therape

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Taking the production of 1000 tablets of the pharmaceutical tablet product of the present invention as an example, the used bulk drug and auxiliary materials and their proportioning ratio are:

[0019] Ginkgo biloba extract 25g

[0020] Pepper Seed Oil 100g

[0021] Magnesium Stearate 5g

[0022] Starch 370g

[0023] Its preparation process is carried out according to the preparation process of the tablet of the present invention. Each tablet weighs 0.5g, and each tablet contains 125mg of raw material drug, and it is taken orally three times a day, 2 tablets each time.

[0024] Taking the production of 1000 grams of the granule product of the present invention as an example, the used bulk drug and auxiliary materials and their weight ratios are:

[0025] Ginkgo biloba extract 25g

[0026] Pepper Seed Oil 100g

[0027] Sucrose 400g

[0028] Dextrin 475g

[0029] Its preparation process is carried out...

Embodiment 2

[0037] Taking the production of 1000 tablets of the pharmaceutical tablet product of the present invention as an example, the used bulk drug and auxiliary materials and their proportioning ratio are:

[0038] Ginkgo Biloba Extract 41.67g

[0039] Pepper Seed Oil 83.34g

[0040] Magnesium Stearate 5g

[0041] Add starch to 500g

[0042] Its preparation process is carried out according to the preparation process of the tablet of the present invention. Each tablet weighs 0.5g, and each tablet contains 125mg of raw material drug, and it is taken orally three times a day, 2 tablets each time.

[0043] Taking the production of 1000 grams of the granule product of the present invention as an example, the used bulk drug and auxiliary materials and their weight ratios are:

[0044] Ginkgo Biloba Extract 41.67g

[0045] Pepper Seed Oil 83.34g

[0046] Sucrose 400g

[0047] Add dextrin to 1000g

[0048] Its preparati...

Embodiment 3

[0056] Taking the production of 1000 tablets of the pharmaceutical tablet product of the present invention as an example, the used bulk drug and auxiliary materials and their proportioning ratio are:

[0057] Ginkgo Biloba Extract 13.89g

[0058] Pepper Seed Oil 111.12g

[0059] Magnesium Stearate 5g

[0060] Add starch to 500g

[0061] Its preparation process is carried out according to the preparation process of the tablet of the present invention. Each tablet weighs 0.5g, and each tablet contains 125mg of raw material drug, and it is taken orally three times a day, 2 tablets each time.

[0062] Taking the production of 1000 grams of the granule product of the present invention as an example, the used bulk drug and auxiliary materials and their weight ratios are:

[0063] Ginkgo Biloba Extract 13.89g

[0064] Pepper Seed Oil 111.12g

[0065] Sucrose 400g

[0066] Add dextrin to 1000g

[0067] Its preparati...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An orally taken Chinese medicine for treating hyperlipemia is proportionally prepared from gingko leaf and Chinese picklyash oil through extracting active component of gingko leaf, and conventional process. Its advantage is high synergistic action.

Description

technical field [0001] The invention belongs to the technical field of medical preparations containing raw materials or their reaction products with unknown structures, and specifically relates to materials derived from plants. Background technique [0002] Cardiovascular and cerebrovascular diseases are one of the most serious diseases that threaten human beings in the world today. Its morbidity and mortality have surpassed tumor diseases and ranked first. Active treatment of hyperlipidemia is an important way to prevent cardiovascular and cerebrovascular diseases and reduce mortality. Means, the treatment of hyperlipidemia has been paid more and more attention, and blood lipid-lowering drugs have become the focus of modern drug research. At present, the lipid-lowering drugs of Western medicine are mainly statins, phenoxyaromatic acids, and polyunsaturated fatty acids. Since there is no drug that can cure hyperlipidemia so far, clinical Most of the lipid-lowering drugs com...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61P3/06
Inventor 杨铁虹姚秀娟衡亮贾敏梅其炳
Owner FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap